Ventilation and Pulmonary Aeration, Electrical Impedance Tomography, Interscalene Brachial Plexus Block
- Conditions
- Pulmonary VentilationBrachial Plexus Block
- Interventions
- Registration Number
- NCT03577860
- Lead Sponsor
- Federal University of São Paulo
- Brief Summary
Patients with indication of shoulder surgery will be submitted to ultrasound-guided interscalene brachial plexus block with 4ml or 15ml of bupivacaine- epinephrine 0,5%- 1:200,000 at level of C5-6 roots and will be evaluated their ventilation and pulmonary aeration by electrical impedance tomography
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
- shoulder surgery
- indication of interscalene brachial plexus block
- American Society of Anesthesiology Physical Status Classification I or II
Exclusion criteria:
- refuse to participate
- previous lung or diaphragma surgeries
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Bupivacaine 4ml Bupivacaine 4 mL The interscalene brachial plexus block is performed with 4ml at level of C5-6 roots Bupivacaine 15ml Bupivacaine 15 mL The interscalene brachial plexus block is performed with 15ml at level of C5-6
- Primary Outcome Measures
Name Time Method Variation of pulmonary function 4 hour Evaluation of variation of pulmonary aeration and ventilation after interscalene brachial plexus block with 4ml or 15 ml of bupivacaine- epinephrine 0,5%1:200,0000. The pulmonary function will be evaluated by electrical impedance tomography.
- Secondary Outcome Measures
Name Time Method Opioid consumption 24 hours Opioid consumption (Tramal - mg) will be recorded during the first 24 hours.
Post-Operative pain 24 hours The post operative pain will be evaluated using Visual Analog Score for pain during the first 24 hours.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
Federal University of Sao Paulo
🇧🇷Sao Paulo, Brazil
Federal University of Sao Paulo - Hospital Sao Paulo
🇧🇷Sao Paulo, Brazil
Federal University of Sao Paulo🇧🇷Sao Paulo, BrazilLeonardo HC Ferraro, M.D.Principal Investigator
